You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Optimizing the safety of antibody–drug conjugates for patients with solid tumours
|
|---|---|
| Published in |
Nature Reviews Clinical Oncology, June 2023
|
| DOI | 10.1038/s41571-023-00783-w |
| Pubmed ID | |
| Authors |
Paolo Tarantino, Biagio Ricciuti, Shan M. Pradhan, Sara M. Tolaney |
X Demographics
The data shown below were collected from the profiles of 566 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 122 | 22% |
| Spain | 23 | 4% |
| United Kingdom | 20 | 4% |
| France | 19 | 3% |
| Brazil | 16 | 3% |
| Mexico | 14 | 2% |
| Japan | 12 | 2% |
| Canada | 9 | 2% |
| Italy | 9 | 2% |
| Other | 93 | 16% |
| Unknown | 229 | 40% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 344 | 61% |
| Practitioners (doctors, other healthcare professionals) | 116 | 20% |
| Scientists | 91 | 16% |
| Science communicators (journalists, bloggers, editors) | 14 | 2% |
| Unknown | 1 | <1% |
Mendeley readers
The data shown below were compiled from readership statistics for 132 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 132 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 24 | 18% |
| Other | 19 | 14% |
| Student > Ph. D. Student | 14 | 11% |
| Student > Postgraduate | 12 | 9% |
| Student > Master | 5 | 4% |
| Other | 11 | 8% |
| Unknown | 47 | 36% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 22 | 17% |
| Medicine and Dentistry | 22 | 17% |
| Chemistry | 9 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 5% |
| Agricultural and Biological Sciences | 5 | 4% |
| Other | 15 | 11% |
| Unknown | 52 | 39% |
Attention Score in Context
This research output has an Altmetric Attention Score of 350. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 May 2024.
All research outputs
#96,355
of 26,154,283 outputs
Outputs from Nature Reviews Clinical Oncology
#15
of 2,380 outputs
Outputs of similar age
#2,221
of 392,857 outputs
Outputs of similar age from Nature Reviews Clinical Oncology
#1
of 41 outputs
Altmetric has tracked 26,154,283 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,380 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 392,857 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 41 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.